cell-based assay (cba (EUROIMMUN)
Structured Review
Cell Based Assay (Cba, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cba/cell+based+assay/nct06388161-5-2-4
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Neural Autoantibody Prevalence in Patients With New-onset Focal Seizures of Unknown Etiology and a Predictive Scoring Scale Article Snippet: Commercial cell-based assay (CBA; Article Title: Multifactorial analysis of clinical prognosis in patients with anti-N-methyl-D-aspartate receptor encephalitis: a single-centre cohort study. Article Snippet: Study population and diagnostic criteria Patients were included if they met the following established diagnostic criteria for anti-NMDAR encephalitis: (i) presence of one or more of the six major symptom groups (abnormal behaviour or cognitive dysfunction, speech dysfunction, seizures, movement disorders, decreased level of consciousness and autonomic dysfunction or central hypoventilation); (ii) positive testing for NMDAR antibodies in CSF and/or serum samples using a Article Title: The Importance of Bright Spotty Lesions on Magnetic Resonance Imaging in Predicting Chronic Neuropathic Pain in Myelitis Article Snippet: AQP4 IgG tests were performed using indirect immunofluorescence on a substrate of mouse cerebellum and midbrain (before 2017) and using a Article Title: Canine idiopathic generalized tremor syndrome, immune-mediated? Article Snippet: When available, serum and Article Title: Prediction model for severe autoimmune encephalitis: a tool for risk assessment and individualized treatment guidance Article Snippet: Using the cell-based assay (CBA) method: (1) Commercial Article Title: Acute neuronal cell death and neuroinflammation per se do not trigger secondary autoimmune encephalitis in mice. Article Snippet: Autoantibody titers against 49-disease associated antibodies were determined for IgG, IgA and IgM isotypes using commercially available cell-based assays developed for the in vitro diagnostic of autoantibodies in suspected Clinical Proteomics:Article Title: Multifactorial analysis of clinical prognosis in patients with anti-N-methyl-D-aspartate receptor encephalitis: a single-centre cohort study. Article Snippet: .. Anti-NMDAR antibodies were tested in both serum and CSF samples using a commercially available |
